In your experience, what factors prompt you to switch a patient with diabetic macular edema to Eylea HD?  

In my practice, it isn’t switching to longer acting anti-VEGF, it is the treatment of the peripheral retinal ischemia. I often initially treat CSME with Avastin, but I use an IVFA to evaluate and treat the non-perfused retina with laser. It is the PRP that treats the VEGF production driving th...

There is a limited window of added benefit. Mostly, patients stuck between 7 and 10 weeks of Eylea 2 mg are the best candidates. In my experience, most patients will get 1-2 added weeks of control with 8 mg over 2 mg. So 7 weeks is the minimum to stay within labeling and insurance coverage after the...